Logo image of 1PFE.MI

PFIZER INC (1PFE.MI) Stock Fundamental Analysis

BIT:1PFE - Euronext Milan - US7170811035 - Common Stock - Currency: EUR

20.405  -0.16 (-0.78%)

Fundamental Rating

5

Overall 1PFE gets a fundamental rating of 5 out of 10. We evaluated 1PFE against 53 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of 1PFE while its profitability can be described as average. 1PFE scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year 1PFE was profitable.
1PFE had a positive operating cash flow in the past year.
1PFE had positive earnings in each of the past 5 years.
1PFE had a positive operating cash flow in each of the past 5 years.
1PFE.MI Yearly Net Income VS EBIT VS OCF VS FCF1PFE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

The Return On Assets of 1PFE (3.79%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 8.73%, 1PFE is in line with its industry, outperforming 45.28% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.37%, 1PFE is in line with its industry, outperforming 47.17% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1PFE is below the industry average of 15.31%.
Industry RankSector Rank
ROA 3.79%
ROE 8.73%
ROIC 7.37%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.72%
ROIC(5y)10.58%
1PFE.MI Yearly ROA, ROE, ROIC1PFE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 12.62%, 1PFE is in line with its industry, outperforming 56.60% of the companies in the same industry.
In the last couple of years the Profit Margin of 1PFE has declined.
Looking at the Operating Margin, with a value of 27.12%, 1PFE is in the better half of the industry, outperforming 77.36% of the companies in the same industry.
In the last couple of years the Operating Margin of 1PFE has grown nicely.
1PFE has a Gross Margin of 74.57%. This is in the better half of the industry: 1PFE outperforms 64.15% of its industry peers.
1PFE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 27.12%
PM (TTM) 12.62%
GM 74.57%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
1PFE.MI Yearly Profit, Operating, Gross Margins1PFE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1PFE is still creating some value.
The number of shares outstanding for 1PFE has been increased compared to 1 year ago.
Compared to 5 years ago, 1PFE has more shares outstanding
1PFE has a better debt/assets ratio than last year.
1PFE.MI Yearly Shares Outstanding1PFE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
1PFE.MI Yearly Total Debt VS Total Assets1PFE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

1PFE has an Altman-Z score of 2.10. This is not the best score and indicates that 1PFE is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.10, 1PFE is in line with its industry, outperforming 43.40% of the companies in the same industry.
1PFE has a debt to FCF ratio of 5.54. This is a neutral value as 1PFE would need 5.54 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.54, 1PFE perfoms like the industry average, outperforming 45.28% of the companies in the same industry.
1PFE has a Debt/Equity ratio of 0.65. This is a neutral value indicating 1PFE is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.65, 1PFE perfoms like the industry average, outperforming 56.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.54
Altman-Z 2.1
ROIC/WACC1.03
WACC7.16%
1PFE.MI Yearly LT Debt VS Equity VS FCF1PFE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

A Current Ratio of 1.26 indicates that 1PFE should not have too much problems paying its short term obligations.
1PFE has a Current ratio of 1.26. This is in the lower half of the industry: 1PFE underperforms 64.15% of its industry peers.
1PFE has a Quick Ratio of 1.26. This is a bad value and indicates that 1PFE is not financially healthy enough and could expect problems in meeting its short term obligations.
1PFE has a Quick ratio (0.96) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.96
1PFE.MI Yearly Current Assets VS Current Liabilites1PFE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

4

3. Growth

3.1 Past

1PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.06%, which is quite impressive.
1PFE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.06% yearly.
The Revenue has grown by 11.65% in the past year. This is quite good.
Measured over the past years, 1PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)126.06%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%12.2%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-7.82%

3.2 Future

Based on estimates for the next years, 1PFE will show a decrease in Earnings Per Share. The EPS will decrease by -2.82% on average per year.
1PFE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.89% yearly.
EPS Next Y-1.51%
EPS Next 2Y0.72%
EPS Next 3Y0.36%
EPS Next 5Y-2.82%
Revenue Next Year-1.13%
Revenue Next 2Y-0.71%
Revenue Next 3Y-1.29%
Revenue Next 5Y-1.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1PFE.MI Yearly Revenue VS Estimates1PFE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
1PFE.MI Yearly EPS VS Estimates1PFE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.26, the valuation of 1PFE can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of 1PFE indicates a rather cheap valuation: 1PFE is cheaper than 88.68% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of 1PFE to the average of the S&P500 Index (26.30), we can say 1PFE is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.39, the valuation of 1PFE can be described as very cheap.
94.34% of the companies in the same industry are more expensive than 1PFE, based on the Price/Forward Earnings ratio.
1PFE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.26
Fwd PE 7.39
1PFE.MI Price Earnings VS Forward Price Earnings1PFE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

83.02% of the companies in the same industry are more expensive than 1PFE, based on the Enterprise Value to EBITDA ratio.
1PFE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1PFE is cheaper than 79.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.81
EV/EBITDA 6.74
1PFE.MI Per share data1PFE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)6.84
EPS Next 2Y0.72%
EPS Next 3Y0.36%

6

5. Dividend

5.1 Amount

1PFE has a Yearly Dividend Yield of 7.33%, which is a nice return.
Compared to an average industry Dividend Yield of 3.02, 1PFE pays a better dividend. On top of this 1PFE pays more dividend than 98.11% of the companies listed in the same industry.
1PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 7.33%

5.2 History

The dividend of 1PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

121.49% of the earnings are spent on dividend by 1PFE. This is not a sustainable payout ratio.
The Dividend Rate of 1PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP121.49%
EPS Next 2Y0.72%
EPS Next 3Y0.36%
1PFE.MI Yearly Income VS Free CF VS Dividend1PFE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
1PFE.MI Dividend Payout.1PFE.MI Dividend Payout, showing the Payout Ratio.1PFE.MI Dividend Payout.PayoutRetained Earnings

PFIZER INC

BIT:1PFE (6/5/2025, 7:00:00 PM)

20.405

-0.16 (-0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners67.49%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap116.01B
Analysts70
Price Target26.14 (28.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.33%
Yearly Dividend1.48
Dividend Growth(5Y)3.3%
DP121.49%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.98%
Min EPS beat(2)32.52%
Max EPS beat(2)37.45%
EPS beat(4)4
Avg EPS beat(4)42.48%
Min EPS beat(4)30.28%
Max EPS beat(4)69.69%
EPS beat(8)8
Avg EPS beat(8)54.64%
EPS beat(12)12
Avg EPS beat(12)42.48%
EPS beat(16)16
Avg EPS beat(16)36.05%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-2.36%
Max Revenue beat(2)1.31%
Revenue beat(4)3
Avg Revenue beat(4)4.42%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)17.22%
Revenue beat(8)4
Avg Revenue beat(8)1.74%
Revenue beat(12)8
Avg Revenue beat(12)3.33%
Revenue beat(16)10
Avg Revenue beat(16)3%
PT rev (1m)1.25%
PT rev (3m)-14%
EPS NQ rev (1m)-1.74%
EPS NQ rev (3m)-0.28%
EPS NY rev (1m)2.57%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-1.44%
Revenue NY rev (1m)-0.93%
Revenue NY rev (3m)-1.06%
Valuation
Industry RankSector Rank
PE 7.26
Fwd PE 7.39
P/S 2.12
P/FCF 11.81
P/OCF 9.47
P/B 1.47
P/tB N/A
EV/EBITDA 6.74
EPS(TTM)2.81
EY13.77%
EPS(NY)2.76
Fwd EY13.54%
FCF(TTM)1.73
FCFY8.47%
OCF(TTM)2.15
OCFY10.56%
SpS9.62
BVpS13.91
TBVpS-4.94
PEG (NY)N/A
PEG (5Y)6.84
Profitability
Industry RankSector Rank
ROA 3.79%
ROE 8.73%
ROCE 9.87%
ROIC 7.37%
ROICexc 8.2%
ROICexgc 39.02%
OM 27.12%
PM (TTM) 12.62%
GM 74.57%
FCFM 17.96%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.72%
ROIC(5y)10.58%
ROICexc(3y)12.29%
ROICexc(5y)12.49%
ROICexgc(3y)49.08%
ROICexgc(5y)45.53%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexcg growth 3Y-10.89%
ROICexcg growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.54
Debt/EBITDA 2.45
Cap/Depr 40.16%
Cap/Sales 4.43%
Interest Coverage 5.35
Cash Conversion 58.69%
Profit Quality 142.33%
Current Ratio 1.26
Quick Ratio 0.96
Altman-Z 2.1
F-Score8
WACC7.16%
ROIC/WACC1.03
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)126.06%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%12.2%
EPS Next Y-1.51%
EPS Next 2Y0.72%
EPS Next 3Y0.36%
EPS Next 5Y-2.82%
Revenue 1Y (TTM)11.65%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-7.82%
Revenue Next Year-1.13%
Revenue Next 2Y-0.71%
Revenue Next 3Y-1.29%
Revenue Next 5Y-1.89%
EBIT growth 1Y56.33%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year21.61%
EBIT Next 3Y6.42%
EBIT Next 5Y4.91%
FCF growth 1Y-44.47%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y-41.56%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%